About James Clemmer
On AngioDynamics’ fiscal 2026 fourth quarter and full year earnings call, James Clemmer stated that the company is “delivering above market profitable growth consistently” and “taking share in the markets we set out to win.” He said the company’s business model “can fund growth, absorb outside headwinds like tariffs, generate cash, and still expand profitability.” Clemmer also noted that the company has a “clean debt-free balance sheet” and intends to continue investing while improving profitability.
Clemmer announced during the call that he intends to retire after a decade with the company. He said the board is conducting a search with a leading executive search firm to identify his successor, which he expects to occur during the first half of fiscal 2027. He described the company as having “a good balance today with our medical device products that provide us with the cash and stability to fund our medical technology investments going forward.”
Source: AI-verified profile updated from James Clemmer's recent appearances.
Browse all interviews →
Transcript (1 segments)
N
Narrator0:00
Get ready for a groundbreaking announcement. Angiodynamics, a medical technology pioneer, is set to make waves at the UBS Global Healthcare Conference on November 10th, 2025. But here's where it gets intriguing. This event showcases the company's commitment to revolutionizing vascular health and cancer treatment. Angiodynamics, leading the charge in vascular health and cancer care. Angiodynamics, headquartered in Latham, New York, is a trailblazer in the medical technology industry. Their focus: restoring healthy blood flow and expanding treatment options for cancer patients. With a mission to improve quality of life, they've developed innovative technologies that are making a real impact in fast-growing healthcare markets. The power of innovation. The company's innovative devices and technologies are not just cutting edge, they're life-changing. Angiodynamics products are chosen by top physicians to address unmet patient needs. Their website www.angiodynamics.com provides a wealth of information about their life-saving work. A live webcast and replay. For those unable to attend the UBS Global Healthcare Conference, Angiodynamics has you covered. A live webcast of the fireside chat will be available through the investors section of their website. And if you miss it live, don't worry. The replay will be available shortly after the event. The future of healthcare. Angiodynamics is not just a company. They're a force for positive change in the healthcare industry. With their dedication to innovation and patient-centric care, they're shaping the future of vascular health and cancer treatment. And this is the part most people miss. The impact of these advancements extends far beyond the conference room. It's about real people, real lives, and real hope. So, what do you think? Are you excited to see the impact of Angiodynamics' participation in this conference? Share your thoughts and let's discuss the future of healthcare together.
